Societe Generale set a €117.00 ($137.65) price target on Bayer AG (FRA:BAYN) in a report published on Tuesday, July 4th. The brokerage currently has a neutral rating on the healthcare company’s stock.

Other research analysts also recently issued research reports about the stock. Deutsche Bank AG set a €120.00 ($141.18) price target on shares of Bayer AG and gave the stock a buy rating in a research report on Tuesday, April 11th. Sanford C. Bernstein set a €122.00 ($143.53) price objective on Bayer AG and gave the stock a buy rating in a report on Tuesday, April 4th. Warburg Research set a €118.00 ($138.82) price objective on Bayer AG and gave the stock a buy rating in a report on Tuesday, April 4th. J P Morgan Chase & Co reissued a buy rating on shares of Bayer AG in a report on Tuesday, April 4th. Finally, Citigroup Inc. reissued a buy rating and set a price objective on shares of Bayer AG in a report on Monday, April 3rd. Nine analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company currently has a consensus rating of Buy and an average price target of €120.27 ($141.50).

Shares of Bayer AG (FRA:BAYN) traded up 1.122% during trading on Tuesday, reaching €107.467. 3,556 shares of the company’s stock traded hands. The company has a market capitalization of €93.72 billion and a price-to-earnings ratio of 18.590. Bayer AG has a 1-year low of €85.72 and a 1-year high of €123.83. The stock has a 50-day moving average of €114.90 and a 200-day moving average of €110.41.

WARNING: This piece was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/04/bayer-ag-frabayn-pt-set-at-117-00-by-societe-generale-updated-updated-updated.html.

About Bayer AG

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Stock Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related stocks with our FREE daily email newsletter.